ELUT Q3 2023 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$47M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+4.8% YoY

Gross Profit

$3M46.4% margin

Operating Income

-$7M-120.3% margin

Net Income

-$10M-159.1% margin

EPS (Diluted)

$-0.57

QoQ Revenue Growth

-3.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$55M

Total Liabilities

$84M

Stockholders' Equity

-$29M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	+4.8%
Gross Profit	$3M	$3M	-3.3%
Operating Income	-$7M	-$9M	+17.8%
Net Income	-$10M	-$10M	+1.6%